
Glimidoze M 2mg/500mg Tablet SR
Marketer
Calen Biotech
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Glimidoze M 2mg/500mg Tablet SR
Diabetic patients (adults) utilize Glimidoze M 2mg/500mg SR tablets, a dual-action antidiabetic medication, to manage type 2 diabetes mellitus. This formulation regulates blood glucose effectively. Administer this medication orally with food, consistently at the same time daily for optimal results. Dosage is determined and adjusted by your physician based on your blood sugar responses. Continuous use is crucial; discontinuation without medical guidance can lead to elevated blood sugar, increasing the risk of kidney complications, vision loss, neuropathy, and limb damage. This medicine is a component of a comprehensive diabetes management plan, incorporating a healthy diet, regular exercise, and weight management as directed by your healthcare provider. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to identify symptoms like sweating, dizziness, headache, and tremors, and have readily available glucose sources (sugary foods or juice) to counteract it. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your doctor before commencing treatment. Consult your physician before use if pregnant or breastfeeding. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are necessary.
Primary Ingredients of Glimidoze M 2mg/500mg Tablet SR
The provided text is "undefined," so there is nothing to rephrase.
Uses of Glimidoze M 2mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimidoze M 2mg/500mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Glimidoze M 2mg/500mg Sustained-Release tablets with a meal.
Common Side effects of Glimidoze M 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimidoze M 2mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimidoze M 2mg/500mg SR tablet whole; avoid chewing, crushing, or breaking it. Consume this medicine with a meal.
How Glimidoze M 2mg/500mg Tablet SR works:
Glimidoze M 2mg/500mg extended-release tablets combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Glimidoze M 2mg/500mg SR tablet use is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimidoze M 2mg/500mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingUNSAFE
Sustained-release Glimidoze M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Impaired driving may result from excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Glimidoze M 2mg/500mg SR tablets, potentially requiring dosage modification. Consult a physician for guidance. Glimidoze M 2mg/500mg SR tablets are contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimidoze M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician. For those with mild to moderate liver disease, Glimidoze M 2mg/500mg SR tablets are typically initiated at a low dose; however, their use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glimidoze M 2mg/500mg Tablet SR :
Should you forget to take a Glimidoze M 2mg/500mg SR tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimidoze M 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
